Isolated Lymph Node Metastasis as Initial Presentation of Collecting Duct Carcinoma on 68Ga-Pentixafor PET/CT.

IF 9.6 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Clinical Nuclear Medicine Pub Date : 2025-01-29 DOI:10.1097/RLU.0000000000005663

Zibei Wan, Feiyu Zhang, Kan Wang, Ya Liu, Zhanwen Huang

引用次数: 0

Abstract

Abstract: A 64-year-old man was admitted to the hospital with low back pain. Enhanced CT imaging revealed an isolated retroperitoneal mass. Since primary retroperitoneal lymphoma could not be ruled out, the patient was enrolled in our clinical trial of 68Ga-pentixafor PET/CT. The mass exhibited intense uptake of 68Ga-pentixafor and was subsequently confirmed as lymph node metastasis originating from collecting duct carcinoma. Our case demonstrated that 68Ga-pentixafor may lack specificity in distinguishing primary retroperitoneal lymphomas from other conditions.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Nuclear Medicine 医学-核医学

CiteScore

2.90

自引率

31.10%

发文量

1113

审稿时长

2 months

期刊介绍： Clinical Nuclear Medicine is a comprehensive and current resource for professionals in the field of nuclear medicine. It caters to both generalists and specialists, offering valuable insights on how to effectively apply nuclear medicine techniques in various clinical scenarios. With a focus on timely dissemination of information, this journal covers the latest developments that impact all aspects of the specialty. Geared towards practitioners, Clinical Nuclear Medicine is the ultimate practice-oriented publication in the field of nuclear imaging. Its informative articles are complemented by numerous illustrations that demonstrate how physicians can seamlessly integrate the knowledge gained into their everyday practice.